Suppr超能文献

肿瘤坏死因子受体2信号转导分子TRAF2和c-IAP1是肿瘤坏死因子受体1信号复合物的组成成分。

The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.

作者信息

Shu H B, Takeuchi M, Goeddel D V

机构信息

Tularik, Inc., South San Francisco, CA 94080, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13973-8. doi: 10.1073/pnas.93.24.13973.

Abstract

The two cell surface receptors for tumor necrosis factor (TNF) interact with a number of intracellular signal transducing proteins. The association of TRADD, a 34-kDa cytoplasmic protein containing a C-terminal death domain, with aggregated TNF receptor 1 (TNF-R1) through their respective death domains leads to NF-kappa B activation and programmed cell death. In contrast, TNF receptor 2 (TNF-R2) interacts with the TNF receptor associated factors 2/1 (TRAF2/TRAF1) heterocomplex, which mediates the recruitment of two cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) to TNF-R2. Here we show that the TNF-R2 signal transducers TRAF2 and c-IAP1 are a part of the TNF-R1 signaling complex. The recruitment of TRAF2 and c-IAP1 to TNF-R1 is TNF-dependent, is mediated by TRADD, and is independent of TNF-R2. These data establish the physiological involvement of TRAF2 and c-IAP1 in TNF-R1 signaling and help provide a molecular explanation for both the overlapping and distinct signals generated by the two TNF receptors.

摘要

肿瘤坏死因子(TNF)的两种细胞表面受体与多种细胞内信号转导蛋白相互作用。TRADD是一种34 kDa的细胞质蛋白,含有一个C末端死亡结构域,它通过各自的死亡结构域与聚集的肿瘤坏死因子受体1(TNF-R1)结合,导致核因子κB激活和程序性细胞死亡。相比之下,肿瘤坏死因子受体2(TNF-R2)与肿瘤坏死因子受体相关因子2/1(TRAF2/TRAF1)异源复合物相互作用,该复合物介导两种细胞凋亡抑制蛋白(c-IAP1和c-IAP2)募集到TNF-R2。在这里,我们表明TNF-R2信号转导分子TRAF2和c-IAP1是TNF-R1信号复合物的一部分。TRAF2和c-IAP1募集到TNF-R1是TNF依赖性的,由TRADD介导,且不依赖于TNF-R2。这些数据证实了TRAF2和c-IAP1在TNF-R1信号传导中的生理作用,并有助于为两种TNF受体产生的重叠和不同信号提供分子解释。

相似文献

引用本文的文献

8
Ripks and Neuroinflammation.Ripks 与神经炎症
Mol Neurobiol. 2024 Sep;61(9):6771-6787. doi: 10.1007/s12035-024-03981-4. Epub 2024 Feb 13.
9
[Not Available].[无可用内容]
Cell Insight. 2023 Dec 17;3(1):100143. doi: 10.1016/j.cellin.2023.100143. eCollection 2024 Feb.
10
4-1BB immunotherapy: advances and hurdles.4-1BB 免疫疗法:进展与障碍。
Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验